NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
Back to search
Official data from USPTO
TEXAS CANCER INTERCEPTION INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TEXAS CANCER INTERCEPTION INSTITUTE
ST13
US500000098072826Class
42, 44
Filing
98072826
Registration
7813114
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/27/2025
Trademark type
Word
Nice classes
42, 44
Filing date
07/06/2023
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
03/27/2025
First use in commerce
03/27/2025
Drawing code
4
Owner type
54
Owner location
DALLAS, TX
Examiner
SMITH, REBECCA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BAYLOR SCOTT & WHITE HEALTH
Baylor Scott & White Holdings
Representatives
Alicia Morris Groos PIRKEY BARBER PLLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research services in the field of oncology; providing medical research services in the field of cancer and oncology
Class 44
providing medical information; providing healthcare information in the field of cancer and oncology.
Publications
History of USPTO decisions and trademark events.
27 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/27/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/21/2025
IUAA
USE AMENDMENT ACCEPTED
04/20/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/18/2025
IUAF
USE AMENDMENT FILED
04/18/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/18/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/22/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/16/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/16/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/20/2024
GNFR
FINAL REFUSAL E-MAILED
10/20/2024
CNFR
FINAL REFUSAL WRITTEN
10/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/10/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2024
GNRT
NON-FINAL ACTION E-MAILED
03/22/2024
CNRT
NON-FINAL ACTION WRITTEN
03/22/2024
DOCK
ASSIGNED TO EXAMINER
03/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2023
NWAP
NEW APPLICATION ENTERED
07/10/2023
Continuous trademark protection
Get notified about every new filing that threatens TEXAS CANCER INTERCEPTION INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.